Trials / Withdrawn
WithdrawnNCT02871310
Vasoactive Effects of IQP-AS-118 in Healthy Individuals
Randomized, Double-Blind, Placebo-Controlled, Monocenter, Crossover Investigation to Evaluate the Vasoactive Effects of IQP-AS-118 in Healthy Individuals: A Pilot Study
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- InQpharm Group · Industry
- Sex
- All
- Age
- 45 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The main objective of this study is to evaluate the benefit of IQP-AS-118 on the vasoactive effects in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | IQP-AS-118 | 1 tablet in the morning |
| DIETARY_SUPPLEMENT | Placebo | 1 tablet in the morning |
Timeline
- Start date
- 2018-03-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2016-08-18
- Last updated
- 2020-02-12
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02871310. Inclusion in this directory is not an endorsement.